ClinicalTrials.Veeva

Menu

Clinical Performance of Three Universal Adhesives in Posterior Restorations

M

Mansoura University

Status

Enrolling

Conditions

Recurrent Caries

Treatments

Other: Universal adhesives application
Other: universal adhesive with bioactive properties
Other: Fluoride-releasing universal adhesive

Study type

Interventional

Funder types

Other

Identifiers

NCT05696431
A01041022

Details and patient eligibility

About

This study was designed to evaluate and compare the two-year clinical performance of three universal adhesives in posterior composite restorations, based on International dental federation (FDI) criteria.

Full description

The description of the experimental design will follow the Consolidated Standards of Reporting Trials (CONSORT) statement. The present study will be a double blinded (patients and examiner) randomized clinical trial anticipating the split-mouth design. 30 adult patients seeking dental treatment in Operative Department clinic at Faculty of Dentistry, Mansoura University will be enrolled in the current study with a total of 90 teeth with Class I or II posterior composite restorations.

No advertisement will be made for participant recruitment, forming a sample of convenience. Each patient will sign a consent form before participating in the current study. The study will be conducted from November 2022 to November 2024 as a part of Doctoral dissertation. Mansoura University institution's ethics committee approved the form and protocol before conducting the study. The sample size was calculated based on a previous study with a similar study design. Parameters including a significance level of 5% (p < 0.05) and a power of 80% were used to calculate an appropriate sample size of 28 cases. Allowing for a 20% drop-out rate, the total sample size was set at 30 cases.

Enrollment

30 estimated patients

Sex

All

Ages

21 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients will have at least 3 posterior teeth with carious lesions of ICDAS score 4, or 5.
  • The teeth will have to be vital, without spontaneous pain and/or mobility.
  • Patients must have a good oral hygiene.
  • Patients with normal and full occlusion.

Exclusion criteria

  • High caries risk patients with extremely poor oral hygiene.
  • Patients with abutments.
  • Patients with heavy bruxism habits and clenching.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

30 participants in 3 patient groups, including a placebo group

Universal adhesive
Placebo Comparator group
Description:
After preparation of three posterior cavities in each patient. The cavities will be randomly divided into three groups according to the type of the adhesive used. This group will receive a universal adhesive as control group.
Treatment:
Other: Universal adhesives application
Fluoride-releasing universal adhesive
Active Comparator group
Description:
After preparation of three posterior cavities in each patient. The cavities will be randomly divided into three groups according to the type of the adhesive used. This group will receive a Fluoride-releasing universal adhesive.
Treatment:
Other: Fluoride-releasing universal adhesive
Universal adhesive with bioactive properties
Active Comparator group
Description:
After preparation of three posterior cavities in each patient. The cavities will be randomly divided into three groups according to the type of the adhesive used.This group will receive a universal adhesive with bioactive properties.
Treatment:
Other: universal adhesive with bioactive properties

Trial contacts and locations

1

Loading...

Central trial contact

Yassmine F El-Sayed, Assis.Lec

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems